Corticosteroids and ibuprofen in cystic fibrosis.
作者信息
Balfour-Lynn I M, Dezateux C
出版信息
Thorax. 1999 Jul;54(7):657. doi: 10.1136/thx.54.7.655d.
Abstract
摘要
相似文献
1
Corticosteroids and ibuprofen in cystic fibrosis.皮质类固醇与布洛芬在囊性纤维化中的应用
Thorax. 1999 Jul;54(7):657. doi: 10.1136/thx.54.7.655d.
2
The use of anti-inflammatory medications in cystic fibrosis: trends and physician attitudes.囊性纤维化中抗炎药物的使用：趋势与医生态度
Chest. 1999 Apr;115(4):1053-8. doi: 10.1378/chest.115.4.1053.
3
Non! to non-steroidal anti-inflammatory therapy for inflammatory lung disease in cystic fibrosis (at least at the moment).
J Pediatr. 2007 Sep;151(3):228-30. doi: 10.1016/j.jpeds.2007.06.019.
4
Targeting inflammation in cystic fibrosis.针对囊性纤维化中的炎症
Respiration. 2010;79(3):189-90. doi: 10.1159/000264605. Epub 2009 Dec 2.
5
Adjunctive therapy in cystic firbrosis (CF).囊性纤维化（CF）的辅助治疗。
Pediatr Infect Dis J. 1998 Apr;17(4):341-2. doi: 10.1097/00006454-199804000-00014.
6
Use of high-dose ibuprofen in a pediatric cystic fibrosis center.高剂量布洛芬在儿科囊性纤维化中心的应用。
J Cyst Fibros. 2007 Apr;6(2):153-8. doi: 10.1016/j.jcf.2006.06.003. Epub 2006 Jul 17.
7
Ibuprofen therapy for cystic fibrosis lung disease: revisited.布洛芬治疗囊性纤维化肺病：再探讨
Curr Opin Pulm Med. 2008 Nov;14(6):567-73. doi: 10.1097/MCP.0b013e32831311e8.
8
Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis.布洛芬的临床应用与囊性纤维化儿童的第一秒用力呼气量（FEV1）下降较慢有关。
Am J Respir Crit Care Med. 2007 Dec 1;176(11):1084-9. doi: 10.1164/rccm.200702-181OC. Epub 2007 Sep 13.
9
Treatment of airway inflammation in cystic fibrosis.囊性纤维化气道炎症的治疗
Curr Opin Pulm Med. 1996 Nov;2(6):452-6.
10
High-dose ibuprofen therapy associated with esophageal ulceration after pneumonectomy in a patient with cystic fibrosis: a case report.高剂量布洛芬治疗与一名囊性纤维化患者肺切除术后食管溃疡相关：病例报告
BMC Pediatr. 2004 Sep 13;4:19. doi: 10.1186/1471-2431-4-19.
引用本文的文献
1
Inhaled corticosteroids for cystic fibrosis.用于囊性纤维化的吸入性皮质类固醇。
Cochrane Database Syst Rev. 2019 Jul 4;7(7):CD001915. doi: 10.1002/14651858.CD001915.pub6.
2
Corticosteroid use and increased CXCR2 levels on leukocytes are associated with lumacaftor/ivacaftor discontinuation in cystic fibrosis patients homozygous for the F508del CFTR mutation.皮质类固醇的使用和白细胞中 CXCR2 水平的升高与囊性纤维化患者中 F508del CFTR 突变纯合子的 lumacaftor/ivacaftor 停药有关。
PLoS One. 2018 Dec 12;13(12):e0209026. doi: 10.1371/journal.pone.0209026. eCollection 2018.
3
A pilot trial on safety and efficacy of erythrocyte-mediated steroid treatment in CF patients.一项关于红细胞介导的类固醇治疗囊性纤维化（CF）患者安全性和有效性的初步试验。
BMC Pediatr. 2006 May 24;6:17. doi: 10.1186/1471-2431-6-17.
4
Measuring and reporting quality of life outcomes in clinical trials in cystic fibrosis: a critical review.测量和报告囊性纤维化临床试验中的生活质量结果：一项批判性综述。
Health Qual Life Outcomes. 2005 Mar 24;3:19. doi: 10.1186/1477-7525-3-19.
5
"CF asthma": what is it and what do we do about it?“囊性纤维化相关性哮喘”：它是什么以及我们该如何应对？
Thorax. 2002 Aug;57(8):742-8. doi: 10.1136/thorax.57.8.742.
6
Treatment of severe small airways disease in children with cystic fibrosis: alternatives to corticosteroids.囊性纤维化患儿严重小气道疾病的治疗：皮质类固醇激素的替代疗法
Paediatr Drugs. 2002;4(6):381-9. doi: 10.2165/00128072-200204060-00005.
Zotero 插件